<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35478078</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1178-1661</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The patient</Title><ISOAbbreviation>Patient</ISOAbbreviation></Journal><ArticleTitle>Long COVID Citizen Scientists: Developing a Needs-Based Research Agenda by Persons Affected by Long COVID.</ArticleTitle><Pagination><StartPage>565</StartPage><EndPage>576</EndPage><MedlinePgn>565-576</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40271-022-00579-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">Long-term health consequences following acute SARS-CoV-2 infection, referred to as post-COVID-19 condition or Long COVID, are increasing, with population-based prevalence estimates for adults at around 20%. Persons affected by Long COVID report various health problems, yet evidence to guide clinical decision making remains scarce.</AbstractText><AbstractText Label="OBJECTIVE">The present study aimed to identify Long COVID research priorities using a citizen science approach and solely considering the needs of those affected.</AbstractText><AbstractText Label="METHODS">This citizen science study followed an iterative process of patient needs identification, evaluation and prioritisation. A Long COVID Citizen Science Board (21 persons with Long COVID, and seven with myalgic encephalomyelitis/chronic fatigue syndrome) and a Long COVID Working Group (25 persons with Long COVID, four patients with myalgic encephalomyelitis/chronic fatigue syndrome and one relative) were formed. The study included four activities: three remote meetings and one online survey. First, Board members identified the needs and research questions. Second, Working Group members and persons affected by Long COVID (241 respondents, 85.5% with Long COVID, 14.5% with myalgic encephalomyelitis/chronic fatigue syndrome and 7.1% relatives) evaluated the research questions on a 1-5 Likert scale using an online survey. Then the Board gave feedback on this evaluation. Finally, Board members set the priorities for research through voting and discussion.</AbstractText><AbstractText Label="RESULTS">Sixty-eight research questions were generated by the Board and categorised into four research domains (medicine, healthcare services, socioeconomics and burden of disease) and 14 subcategories. Their average importance ratings were moderate to high and varied from 3.41 (standard deviation = 1.16) for sex-specific diagnostics to 4.86 (standard deviation = 0.41) for medical questions on treatment. Five topics were prioritised: "treatment, rehabilitation and chronic care management", "availability of interfaces for treatment continuity", "availability of healthcare structures", "awareness and knowledge among professionals" and "prevalence of Long COVID in children and adolescents".</AbstractText><AbstractText Label="CONCLUSIONS">To our knowledge, this is the first study developing a citizen-driven, explicitly patient-centred research agenda with persons affected by Long COVID, setting it apart from existing multi-stakeholder efforts. The identified priorities could guide future research and funding allocation. Our methodology establishes a framework for citizen-driven research agendas, suitable for transfer to other diseases.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ziegler</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9907-5787</Identifier><AffiliationInfo><Affiliation>Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschengraben 84 CH-8001, Zurich, Switzerland. sarah.ziegler@uzh.ch.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raineri</LastName><ForeName>Alessia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschengraben 84 CH-8001, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nittas</LastName><ForeName>Vasileios</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschengraben 84 CH-8001, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rangelov</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Altea Long COVID Network Association, Wallisellen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vollrath</LastName><ForeName>Fabian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Altea Long COVID Network Association, Wallisellen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Britt</LastName><ForeName>Chantal</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Long Covid Schweiz, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puhan</LastName><ForeName>Milo A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschengraben 84 CH-8001, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Patient</MedlineTA><NlmUniqueID>101309314</NlmUniqueID><ISSNLinking>1178-1653</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="plain-language-summary" Language="eng"><AbstractText>Research shows that about one in five adults may experience lasting symptoms months after their initial coronavirus infection. Persons with Long COVID have various health problems and doctors often do not know their patients&#x2019; most urgent needs. The project directly involved people with Long COVID who were asked to express, discuss and rank how research could meet their needs. For that, a Board and a Working Group were formed to take part in three online board meetings and one online questionnaire. In the meetings, the Board formulated 68 research questions, which fall into four research areas: (1) medicine, (2) healthcare services, (3) socioeconomics and (4) burden of disease. The Working Group and other persons affected by Long COVID ranked the importance of these 68 research questions using an online questionnaire. Most questions were ranked as somehow or very important, confirming the relevance of the selected research questions for patients with Long COVID. Finally, the Board selected its top five research topics: &#x201c;treatment, rehabilitation and chronic care management&#x201d;, &#x201c;availability of interfaces for treatment continuity&#x201d;, &#x201c;availability of healthcare structures&#x201d;, &#x201c;awareness and knowledge among professionals&#x201d; and &#x201c;prevalence of Long COVID in children and adolescents&#x201d;. This result will help prioritise and finance future research that is valued and needed by people with Long COVID.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></OtherAbstract><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>28</Day><Hour>5</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35478078</ArticleId><ArticleId IdType="pmc">PMC9046008</ArticleId><ArticleId IdType="doi">10.1007/s40271-022-00579-7</ArticleId><ArticleId IdType="pii">10.1007/s40271-022-00579-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nittas V, Puhan MA, Raineri A, Gao M, West E. Literature screening report long COVID: evolving definitions, burden of disease and socio-economic consequences. Zurich; 2021. https://www.bag.admin.ch/bag/de/home/krankheiten/ausbrueche-epidemien-pandemien/aktuelle-ausbrueche-epidemien/novel-cov/situation-schweiz-und-international/forschung-wissenschaft.html#99203729. Accessed 2 Apr 2022.</Citation></Reference><Reference><Citation>Raman B, Cassar MP, Tunnicliffe EM, Filippini N, Griffanti L, Alfaro-Almagro F, et al. Living with COVID-19 second review. Natl Inst Health Res. 2021 doi: 10.3310/themedreview_45225.</Citation><ArticleIdList><ArticleId IdType="doi">10.3310/themedreview_45225</ArticleId></ArticleIdList></Reference><Reference><Citation>Menges D, Ballouz T, Anagnostopoulos A, Aschmann HE, Domenghino A, Fehr JS, et al. Burden of post-COVID-19 syndrome and implications for healthcare service planning: a population-based cohort study. PLoS ONE. 2021 doi: 10.1371/journal.pone.0254523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254523</ArticleId><ArticleId IdType="pmc">PMC8274847</ArticleId><ArticleId IdType="pubmed">34252157</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus 6. 2021. https://apps.who.int/iris/handle/10665/345824. Accessed 2 Apr 2022.</Citation></Reference><Reference><Citation>Moser C. There is now an official definition of long COVID. 2021. https://www.altea-network.com/en/blog/43-long-covid-who-definition/. Accessed 2 Dec 2021.</Citation></Reference><Reference><Citation>NIHR. &#xa3;19.6 million awarded to new reserach studies to help diagnose and treat long COVID. 2021. https://www.nihr.ac.uk/news/196-million-awarded-to-new-research-studies-to-help-diagnose-and-treat-long-covid/28205?pr=. Accessed 26 Oct 2021.</Citation></Reference><Reference><Citation>NIHR. New research into treatment and diagnosis of long COVID. 2021. https://www.gov.uk/government/news/new-research-into-treatment-and-diagnosis-of-long-covid. Accessed 26 Oct 2021.</Citation></Reference><Reference><Citation>KCE. KCE Trial Long COVID call. 2021. https://kce.fgov.be/en/kce-trials-long-covid-call. Accessed 26 Oct 2021.</Citation></Reference><Reference><Citation>SBU. Priority setting of future research into long-term symptoms of Covid-19 infection (post-acute sequelae of Covid-19 or Long Covid). Stockholm: Swedish Agency for Health Technology Assessment and Assessment of Scoial Services (SBU); 2021. https://www.sbu.se/324e. Accessed 2 Apr 2022.</Citation></Reference><Reference><Citation>Yang H, Wang H, Jaenisch R. Research priorities for long COVID: refined through an international multi-stakeholder forum. BMC Med. 2021 doi: 10.1186/s13059-021-02312-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-021-02312-3</ArticleId><ArticleId IdType="pmc">PMC8009733</ArticleId><ArticleId IdType="pubmed">33785027</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirk JL, Ballard HL, Wilderman CC, Phillips T, Wiggins A, Jordan R, et al. Patient participation in scientific research. Ned Tijdschr Geneeskd. 2011 doi: 10.5751/ES-04705-170229.</Citation><ArticleIdList><ArticleId IdType="doi">10.5751/ES-04705-170229</ArticleId></ArticleIdList></Reference><Reference><Citation>Senabre Hidalgo E, Perell&#xf3; J, Becker F, Bonhoure I, Legris M, Cigarini A. Participation and co-creation in citizen science. Sci Citiz Sci. 2021 doi: 10.1007/978-3-030-58278-4_11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-58278-4_11</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham A, Gille D, Puhan MA, ter Riet G, von Wyl V. Defining Core Competencies for epidemiologists in academic settings to tackle tomorrow&#x2019;s health research challenges: a structured, multinational effort. Am J Epidemiol. 2021 doi: 10.1093/aje/kwaa209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwaa209</ArticleId><ArticleId IdType="pmc">PMC7935742</ArticleId><ArticleId IdType="pubmed">33106866</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson W, Wilson M, Nishikawa J, Hayward R. The well-built clinical question: a key to evidence-based decisions. ACP J Club. 1995;123:A12&#x2013;A13. doi: 10.7326/ACPJC-1995-123-3-A12.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/ACPJC-1995-123-3-A12</ArticleId><ArticleId IdType="pubmed">7582737</ArticleId></ArticleIdList></Reference><Reference><Citation>Altea Long COVID Network. Symptoms overview. 2021. https://www.altea-network.com/en/long-covid/symptoms-overview/. Accessed 15 Nov 2021.</Citation></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021 doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, et al. Post-COVID syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021 doi: 10.1136/bmj.n693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantelic M, Alwan N. The stigma is real for people living with long COVID. BMJ Opin. 2021. https://blogs.bmj.com/bmj/2021/03/25/marija-pantelic-and-nisreen-alwan-the-stigma-is-real-for-people-living-with-long-covid/. Accessed 10 Nov 2021.</Citation></Reference><Reference><Citation>Gomolla M. Direkte und indirekte, institutionelle und strukturelle diskriminierung. In: Scherr A, El-Mafaalani A, Handbuch YG, editors. Diskriminierung. Springer Reference Sozialwissenschaften. Wiesbaden: Springer VS; 2016. 10.1007/978-3-658-10976-9_9.</Citation></Reference><Reference><Citation>Heymann J, Raub A, Waisath W, McCormack M, Weistroffer R, Moreno G, et al. Protecting health during COVID-19 and beyond: a global examination of paid sick leave design in 193 countries. Glob Public Health. 2020 doi: 10.1080/17441692.2020.1764076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17441692.2020.1764076</ArticleId><ArticleId IdType="pubmed">32396447</ArticleId></ArticleIdList></Reference><Reference><Citation>McCorkell L, Assaf GS, Davis HE, Wei H, Akrami A. Patient-led research collaborative: embedding patients in the Long COVID narrative. Pain Rep. 2021 doi: 10.1097/PR9.0000000000000913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PR9.0000000000000913</ArticleId><ArticleId IdType="pmc">PMC8112577</ArticleId><ArticleId IdType="pubmed">33987484</ArticleId></ArticleIdList></Reference><Reference><Citation>Radtke T, Ulyte A, Puhan MA, Kriemler S. Long-term symptoms after SARS-CoV-2 infection in children and adolescents. JAMA. 2021 doi: 10.1001/jama.2021.11880/.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.11880/</ArticleId><ArticleId IdType="pmc">PMC8283661</ArticleId><ArticleId IdType="pubmed">34264266</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>